DCTN3

dynactin subunit 3, the group of Dynactin subunits

Basic information

Region (hg38): 9:34613544-34620523

Links

ENSG00000137100NCBI:11258OMIM:607387HGNC:2713Uniprot:O75935AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DCTN3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCTN3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
12
clinvar
12
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 12 0 0

Variants in DCTN3

This is a list of pathogenic ClinVar variants found in the DCTN3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-34613846-A-G not specified Uncertain significance (Oct 22, 2021)2256489
9-34614070-T-C not specified Uncertain significance (Jun 02, 2023)2555662
9-34616089-A-G not specified Uncertain significance (Jan 25, 2023)2469431
9-34617929-C-A not specified Uncertain significance (Jan 10, 2023)2475386
9-34617933-C-T not specified Uncertain significance (Oct 20, 2023)3080651
9-34617955-C-A not specified Uncertain significance (Feb 12, 2024)3080650
9-34618735-T-C not specified Uncertain significance (Jun 27, 2022)2350574
9-34618752-G-T not specified Uncertain significance (Mar 29, 2024)3271158
9-34620398-C-G not specified Uncertain significance (Oct 27, 2022)2215560
9-34620425-C-T not specified Uncertain significance (Jul 20, 2021)2238333
9-34620427-C-A not specified Uncertain significance (Feb 10, 2023)2482907
9-34620442-T-C not specified Uncertain significance (May 04, 2023)2533086
9-34620449-C-T not specified Uncertain significance (May 11, 2022)2289257

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DCTN3protein_codingprotein_codingENST00000259632 76968
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.26e-70.2091257310171257480.0000676
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.350961060.9040.000005631197
Missense in Polyphen3035.9060.83553445
Synonymous-0.3014542.51.060.00000226362
Loss of Function0.2051111.80.9355.04e-7134

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009040.0000904
Ashkenazi Jewish0.00009920.0000992
East Asian0.000.00
Finnish0.00009260.0000924
European (Non-Finnish)0.00009690.0000967
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Together with dynein may be involved in spindle assembly and cytokinesis. {ECO:0000269|PubMed:9722614}.;
Pathway
Vesicle-mediated transport;lissencephaly gene (lis1) in neuronal migration and development;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Regulation of PLK1 Activity at G2/M Transition;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;COPI-independent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;COPI-mediated anterograde transport;M Phase;Cell Cycle;ER to Golgi Anterograde Transport;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Intra-Golgi and retrograde Golgi-to-ER traffic;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Recessive Scores

pRec
0.115

Intolerance Scores

loftool
0.264
rvis_EVS
0.13
rvis_percentile_EVS
62.74

Haploinsufficiency Scores

pHI
0.0896
hipred
N
hipred_score
0.332
ghis
0.592

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
N
gene_indispensability_score
0.307

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Dctn3
Phenotype

Gene ontology

Biological process
G2/M transition of mitotic cell cycle;mitotic cell cycle;endoplasmic reticulum to Golgi vesicle-mediated transport;microtubule-based process;regulation of G2/M transition of mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class II;cytoskeleton-dependent cytokinesis;ciliary basal body-plasma membrane docking
Cellular component
condensed chromosome kinetochore;nucleolus;centrosome;spindle;cytosol;dynactin complex;microtubule;midbody;cleavage furrow;perinuclear region of cytoplasm
Molecular function
structural molecule activity;protein binding